In June 2025, the FDA published a paper on embedding cybersecurity into advanced medical-product manufacturing technologies — a signal that adopting AI in regulated research now carries the same scrutiny as the systems around it. This scorecard estimates how ready your organization is to adopt AI without breaking data integrity, 21 CFR Part 11, or GxP.
1. AI Inventory & Shadow AI
0 / 62. Access Control & Data Governance for AI
0 / 43. Data Integrity / ALCOA+
0 / 64. 21 CFR Part 11
0 / 45. Validation (CSA / CSV)
0 / 46. Human Oversight & Output Review
0 / 47. Vendor & Model Governance
0 / 4Rate all 16 criteria to see your score
Want a Clear Read on Where You Stand?
Our 2-minute security assessment gives you a fast, practical picture of your readiness — no sales call, just a clear next step.
Start the 2-Minute AssessmentNo commitment. No sales pressure. Just actionable guidance.
Shadow AI was involved in 20% of breaches and added about $670K to the average breach cost; 97% of AI-related breaches lacked proper access controls; shadow-AI breaches showed higher rates of intellectual-property theft; and attackers used AI in 16% of breaches — IBM Cost of a Data Breach Report 2025 (DataFence, Bluefin). AI-generated deception, including falsified lab results, is an emerging biotech threat (Zenzero). Regulatory context: the FDA's June 2025 paper on embedding cybersecurity into advanced medical-product manufacturing technologies.
These results are for informational purposes only and do not constitute professional, legal, or regulatory advice. centrexIT makes no guarantees regarding audit or compliance outcomes. Consult qualified professionals before acting on these results.
Want additional insights sent to your inbox?
We'll send a personalized summary with recommendations based on your results.